<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<!--
  ~ Copyright 2015 OpenCB
  ~
  ~ Licensed under the Apache License, Version 2.0 (the "License");
  ~ you may not use this file except in compliance with the License.
  ~ You may obtain a copy of the License at
  ~
  ~     http://www.apache.org/licenses/LICENSE-2.0
  ~
  ~ Unless required by applicable law or agreed to in writing, software
  ~ distributed under the License is distributed on an "AS IS" BASIS,
  ~ WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.
  ~ See the License for the specific language governing permissions and
  ~ limitations under the License.
  -->

<ReleaseSet Dated="2014-09-22" Type="full">

<ClinVarSet ID="3489885">
  <RecordStatus>current</RecordStatus>
  <Title>NM_000719.6(CACNA1C):c.5680+11C&gt;T AND not specified</Title>
  <ReferenceClinVarAssertion DateCreated="2014-01-17" DateLastUpdated="2014-09-22" ID="198468">
    <ClinVarAccession Acc="RCV000079303" Version="1" Type="RCV" DateUpdated="2014-09-22"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2013-02-14">
      <ReviewStatus>classified by single submitter</ReviewStatus>
      <Description>Benign</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ObservedIn>
      <Sample>
        <Origin>germline</Origin>
        <Species TaxonomyId="9606">human</Species>
        <AffectedStatus>unknown</AffectedStatus>
      </Sample>
      <Method>
        <MethodType>clinical testing</MethodType>
      </Method>
      <ObservedData ID="3220704">
        <Attribute Type="Description">not provided</Attribute>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant" ID="93418">
      <Measure Type="single nucleotide variant" ID="99325">
        <Name>
          <ElementValue Type="Preferred">NM_000719.6(CACNA1C):c.5680+11C&gt;T</ElementValue>
        </Name>
        <AttributeSet>
          <Attribute Type="GlobalMinorAlleleFrequency">0.2112(T)</Attribute>
          <XRef DB="dbSNP" ID="66611965"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, coding, LRG" Change="c.5680+11C&gt;T">LRG_334t4:c.5680+11C&gt;T</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, coding, LRG" Change="c.5680+11C&gt;T">LRG_334t1:c.5680+11C&gt;T</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, coding, LRG" Change="c.5785+11C&gt;T">LRG_334t3:c.5785+11C&gt;T</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, coding, LRG" Change="c.5824+11C&gt;T">LRG_334t2:c.5824+11C&gt;T</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, coding, RefSeq" Change="c.5680+11C&gt;T">NM_001129840.1:c.5680+11C&gt;T</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, coding, RefSeq" Change="c.5680+11C&gt;T">NM_000719.6:c.5680+11C&gt;T</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, coding, RefSeq" Change="c.5785+11C&gt;T">NM_001129830.2:c.5785+11C&gt;T</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, coding, RefSeq" Change="c.5824+11C&gt;T">NM_001129827.1:c.5824+11C&gt;T</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, LRG" Change="g.720068C&gt;T">LRG_334:g.720068C&gt;T</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, RefSeqGene" Change="g.720068C&gt;T">NG_008801.2:g.720068C&gt;T</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, top level" Change="g.2685853C&gt;T">NC_000012.12:g.2685853C&gt;T</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, top level, previous" Change="g.2795019C&gt;T">NC_000012.11:g.2795019C&gt;T</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, previous" Change="c.5785+11C&gt;T">NM_001129830.1:c.5785+11C&gt;T</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="Location">NM_000719.6:IVS44</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="MolecularConsequence">intron variant</Attribute>
          <XRef ID="SO:0001627" DB="Sequence Ontology"/>
          <XRef ID="NM_000719.6:c.5680+11C&gt;T" DB="RefSeq"/>
        </AttributeSet>
        <CytogeneticLocation>12p13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" Chr="12" Accession="NC_000012.11" start="2795019" stop="2795019" variantLength="1" referenceAllele="C" alternateAllele="T"/>
        <SequenceLocation Assembly="GRCh38" Chr="12" Accession="NC_000012.12" start="2685853" stop="2685853" variantLength="1" referenceAllele="C" alternateAllele="T"/>
        <MeasureRelationship Type="variant in gene">
          <Name>
            <ElementValue Type="Preferred">calcium channel, voltage-dependent, L type, alpha 1C subunit</ElementValue>
          </Name>
          <Symbol>
            <ElementValue Type="Preferred">CACNA1C</ElementValue>
          </Symbol>
          <AttributeSet>
            <Attribute dateValue="2011-11-17" Type="Haploinsufficiency">Some evidence for dosage pathogenicity</Attribute>
            <Citation>
              <URL>http://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1C</URL>
            </Citation>
          </AttributeSet>
          <AttributeSet>
            <Attribute dateValue="2011-11-17" Type="Triplosensitivity">No evidence available</Attribute>
            <Citation>
              <URL>http://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1C</URL>
            </Citation>
          </AttributeSet>
          <SequenceLocation Assembly="GRCh37" Chr="12" Accession="NC_000012.11" start="2162415" stop="2807114" Strand="+"/>
          <SequenceLocation Assembly="GRCh38" Chr="12" Accession="NC_000012.12" start="1970785" stop="2697948" Strand="+"/>
          <XRef ID="775" DB="Gene"/>
          <XRef Type="MIM" ID="114205" DB="OMIM"/>
        </MeasureRelationship>
        <MeasureRelationship Type="variant in gene">
          <Name>
            <ElementValue Type="Preferred">calcium channel, voltage-dependent, L type, alpha 1C subunit</ElementValue>
          </Name>
          <Symbol>
            <ElementValue Type="Preferred">CACNA1C</ElementValue>
          </Symbol>
          <AttributeSet>
            <Attribute dateValue="2011-11-17" Type="Haploinsufficiency">Some evidence for dosage pathogenicity</Attribute>
            <Citation>
              <URL>http://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1C</URL>
            </Citation>
          </AttributeSet>
          <AttributeSet>
            <Attribute dateValue="2011-11-17" Type="Triplosensitivity">No evidence available</Attribute>
            <Citation>
              <URL>http://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1C</URL>
            </Citation>
          </AttributeSet>
          <SequenceLocation Assembly="GRCh37" Chr="12" Accession="NC_000012.11" start="2162415" stop="2807114" Strand="+"/>
          <SequenceLocation Assembly="GRCh38" Chr="12" Accession="NC_000012.12" start="1970785" stop="2697948" Strand="+"/>
          <XRef ID="775" DB="Gene"/>
          <XRef Type="MIM" ID="114205" DB="OMIM"/>
        </MeasureRelationship>
        <XRef Type="rs" ID="66611965" DB="dbSNP"/>
      </Measure>
      <Name>
        <ElementValue Type="preferred name">NM_000719.6(CACNA1C):c.5680+11C&gt;T</ElementValue>
      </Name>
    </MeasureSet>
    <TraitSet Type="Disease" ID="9590">
      <Trait ID="16789" Type="Disease">
        <Name>
          <ElementValue Type="Preferred">not specified</ElementValue>
        </Name>
      </Trait>
    </TraitSet>
  </ReferenceClinVarAssertion>
  <ClinVarAssertion ID="193265" SubmissionName="EGL001">
    <ClinVarSubmissionID localKey="8749" submitter="Emory Genetics Laboratory" submitterDate="2013-11-21"/>
    <ClinVarAccession Acc="SCV000111173" Version="1" Type="SCV" OrgID="500060" DateUpdated="2014-06-28"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2013-02-14">
      <ReviewStatus>classified by single submitter</ReviewStatus>
      <Description>no known pathogenicity</Description>
      <Citation>
        <URL>http://genetics.emory.edu/egl/emvclass/emvclass.php?approved_symbol=CACNA1C</URL>
      </Citation>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ExternalID DB="Emory Genetics Laboratory" ID="8749" URL="http://genetics.emory.edu/egl/emvclass/emvclass.php?approved_symbol=CACNA1C"/>
    <ObservedIn>
      <Sample>
        <Origin>germline</Origin>
        <Species TaxonomyId="9606">human</Species>
        <AffectedStatus>unknown</AffectedStatus>
        <Gender>mixed</Gender>
      </Sample>
      <Method>
        <MethodType>clinical testing</MethodType>
      </Method>
      <ObservedData>
        <Attribute Type="Description">not provided</Attribute>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant">
      <Measure Type="Variation">
        <AttributeSet>
          <Attribute Type="Location">NM_000719.6:IVS44</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS">NM_000719.6:c.5680+11C&gt;T</Attribute>
        </AttributeSet>
        <MeasureRelationship Type="variant in gene">
          <Symbol>
            <ElementValue Type="Preferred">CACNA1C</ElementValue>
          </Symbol>
        </MeasureRelationship>
        <XRef DB="dbSNP" ID="66611965" Type="rsNumber"/>
      </Measure>
    </MeasureSet>
    <TraitSet Type="Disease">
      <Trait Type="Disease">
        <Name>
          <ElementValue Type="Preferred">AllHighlyPenetrant</ElementValue>
        </Name>
      </Trait>
    </TraitSet>
    <Citation Type="general">
      <ID Source="PubMed">23757202</ID>
    </Citation>
  </ClinVarAssertion>
</ClinVarSet>
<ClinVarSet ID="3193938">
  <RecordStatus>current</RecordStatus>
  <Title>NM_001099274.1(TINF2):c.865_866delCCinsAG (p.Pro289Ser) AND Dyskeratosis congenita autosomal dominant</Title>
  <ReferenceClinVarAssertion DateCreated="2013-01-08" DateLastUpdated="2014-08-05" ID="92828">
    <ClinVarAccession Acc="RCV000032177" Version="1" Type="RCV" DateUpdated="2014-08-05"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2012-05-10">
      <ReviewStatus>classified by single submitter</ReviewStatus>
      <Description>Pathogenic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ObservedIn>
      <Sample>
        <Origin>not provided</Origin>
        <Species TaxonomyId="9606">human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <Purpose>assert pathogenicity</Purpose>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData ID="2861391">
        <Attribute Type="Description">not provided</Attribute>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant" ID="38926">
      <Measure Type="Indel" ID="47529">
        <Name>
          <ElementValue Type="Preferred">NM_001099274.1(TINF2):c.865_866delCCinsAG (p.Pro289Ser)</ElementValue>
        </Name>
        <AttributeSet>
          <Attribute Type="HGVS, coding, RefSeq" Change="c.865_866delCCinsAG">NM_001099274.1:c.865_866delCCinsAG</Attribute>
          <XRef ID="NBK22301" DB="GeneReviews"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, RefSeqGene" Change="g.7060_7061delCCinsAG">NG_016650.1:g.7060_7061delCCinsAG</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, top level" Change="g.24240614_24240615delGGinsCT">NC_000014.9:g.24240614_24240615delGGinsCT</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, top level, previous" Change="g.24709820_24709821delGGinsCT">NC_000014.8:g.24709820_24709821delGGinsCT</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, protein, RefSeq" Change="p.Pro289Ser">NP_001092744.1:p.Pro289Ser</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="MolecularConsequence">missense variant</Attribute>
          <XRef ID="SO:0001583" DB="Sequence Ontology"/>
          <XRef ID="NM_001099274.1:c.865_866delCCinsAG" DB="RefSeq"/>
        </AttributeSet>
        <CytogeneticLocation>14q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" Chr="14" Accession="NC_000014.9" start="24240614" stop="24240615"/>
        <SequenceLocation Assembly="GRCh37" Chr="14" Accession="NC_000014.8" start="24709820" stop="24709821"/>
        <MeasureRelationship Type="variant in gene">
          <Name>
            <ElementValue Type="Preferred">TERF1 (TRF1)-interacting nuclear factor 2</ElementValue>
          </Name>
          <Symbol>
            <ElementValue Type="Preferred">TINF2</ElementValue>
          </Symbol>
          <SequenceLocation Assembly="GRCh37" Chr="14" Accession="NC_000014.8" start="24708848" stop="24711879" Strand="-"/>
          <SequenceLocation Assembly="GRCh38" Chr="14" Accession="NC_000014.9" start="24234247" stop="24243026" Strand="-"/>
          <XRef ID="26277" DB="Gene"/>
          <XRef Type="MIM" ID="604319" DB="OMIM"/>
        </MeasureRelationship>
        <XRef ID="NBK22301" DB="GeneReviews"/>
        <XRef Type="rs" ID="199422318" DB="dbSNP"/>
      </Measure>
      <Name>
        <ElementValue Type="preferred name">NM_001099274.1(TINF2):c.865_866delCCinsAG (p.Pro289Ser)</ElementValue>
      </Name>
    </MeasureSet>
    <TraitSet Type="Disease" ID="1583">
      <Trait ID="4974" Type="Disease">
        <Name>
          <ElementValue Type="Preferred">Dyskeratosis congenita autosomal dominant</ElementValue>
          <XRef ID="Dyskeratosis+Congenita+Autosomal+Dominant/2383" DB="Genetic Alliance"/>
          <XRef ID="6299" DB="Office of Rare Diseases"/>
        </Name>
        <Name>
          <ElementValue Type="Alternate">DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1</ElementValue>
          <XRef Type="MIM" ID="127550" DB="OMIM"/>
          <XRef Type="Allelic variant" ID="602322.0003" DB="OMIM"/>
          <XRef Type="Allelic variant" ID="602322.0001" DB="OMIM"/>
          <XRef Type="Allelic variant" ID="602322.0002" DB="OMIM"/>
          <XRef Type="Allelic variant" ID="602322.0011" DB="OMIM"/>
        </Name>
        <Name>
          <ElementValue Type="Alternate">Dyskeratosis Congenita</ElementValue>
          <XRef ID="NBK22301" DB="GeneReviews"/>
        </Name>
        <Symbol>
          <ElementValue Type="Preferred">DKCA1</ElementValue>
          <XRef Type="MIM" ID="127550" DB="OMIM"/>
        </Symbol>
        <Symbol>
          <ElementValue Type="Alternate">DKCA</ElementValue>
          <XRef ID="6299" DB="Office of Rare Diseases"/>
        </Symbol>
        <AttributeSet>
          <Attribute Type="public definition">Dyskeratosis congenita (DC), a telomere biology disorder, is characterized by a classic triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia. However, the classic triad may not be present in all individuals. People with DC are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML), solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include: abnormal pigmentation changes not restricted to the upper chest and neck, eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), and dental abnormalities (caries, periodontal disease, taurodauntism). Although most persons with DC have normal psychomotor development and normal neurologic function, significant developmental delay is present in the two variants in which additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome). Onset and progression of manifestations of DC vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
          <XRef ID="NBK22301" DB="GeneReviews"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance" integerValue="263">Autosomal recessive inheritance</Attribute>
          <XRef ID="GTR000319388" DB="Ambry Genetics"/>
          <XRef ID="GTR000298122" DB="DNA Diagnostic Laboratory at Johns Hopkins,Johns Hopkins Hospital"/>
          <XRef ID="GTR000510772" DB="Centogene AG  - the Rare Disease Company,Centogene AG"/>
          <XRef ID="GTR000510773" DB="Centogene AG  - the Rare Disease Company,Centogene AG"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance" integerValue="262">Autosomal dominant inheritance</Attribute>
          <XRef ID="GTR000319384" DB="Ambry Genetics"/>
          <XRef ID="GTR000319388" DB="Ambry Genetics"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="age of onset">Childhood</Attribute>
          <XRef ID="1775" DB="Orphanet"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="prevalence">1-9 / 1 000 000</Attribute>
          <XRef ID="1775" DB="Orphanet"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="mode of inheritance">Variable</Attribute>
          <XRef ID="GTR000319389" DB="Ambry Genetics"/>
        </AttributeSet>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301779</ID>
        </Citation>
        <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
          <ID Source="PubMed">21610750</ID>
        </Citation>
        <XRef ID="NBK22301" DB="GeneReviews"/>
        <XRef ID="C1851970" DB="MedGen"/>
        <XRef ID="1775" DB="Orphanet"/>
        <XRef Type="MIM" ID="127550" DB="OMIM"/>
      </Trait>
    </TraitSet>
  </ReferenceClinVarAssertion>
  <ClinVarAssertion ID="92226">
    <ClinVarSubmissionID title="NM_001099274.1:c.865_866delCCinsAG and Dyskeratosis Congenita" localKey="NM_001099274.1:c.865_866delCCinsAG_NBK22301" submitterDate="2013-01-08" submitter="GeneReviews"/>
    <ClinVarAccession Acc="SCV000055756" Version="1" Type="SCV" OrgID="500062" DateUpdated="2014-06-28"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2012-05-10">
      <Description>pathologic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ExternalID DB="GeneReviews" ID="NBK22301"/>
    <ObservedIn>
      <Sample>
        <Origin>not provided</Origin>
        <Species>human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <Purpose>Assert pathogenicity</Purpose>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData>
        <Attribute Type="Description">not provided</Attribute>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant">
      <Measure Type="Variation">
        <AttributeSet>
          <Attribute Type="HGVS">NM_001099274.1:c.865_866delCCinsAG</Attribute>
        </AttributeSet>
        <XRef DB="dbSNP" ID="199422318"/>
      </Measure>
    </MeasureSet>
    <TraitSet Type="Disease">
      <Trait Type="Disease">
        <Name>
          <ElementValue Type="Preferred">Dyskeratosis Congenita</ElementValue>
        </Name>
        <XRef DB="GeneReviews" ID="NBK22301"/>
        <XRef DB="OMIM" Type="MIM Number" ID="127550"/>
      </Trait>
    </TraitSet>
  </ClinVarAssertion>
</ClinVarSet>
<ClinVarSet ID="3192671">
  <RecordStatus>current</RecordStatus>
  <Title>NM_005270.4(GLI2):c.864_865delCC (p.His289Profs) AND Holoprosencephaly 9</Title>
  <ReferenceClinVarAssertion DateCreated="2012-09-14" DateLastUpdated="2014-08-05" ID="88504">
    <ClinVarAccession Acc="RCV000030729" Version="22" Type="RCV" DateUpdated="2014-08-05"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2014-01-24">
      <ReviewStatus>classified by single submitter</ReviewStatus>
      <Description>Pathogenic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ObservedIn>
      <Sample>
        <Origin>germline</Origin>
        <Species TaxonomyId="9606">human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <MethodType>literature only</MethodType>
      </Method>
      <Method>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData ID="2788085">
        <Attribute Type="Description">In a Brazilian girl with HPE9 (610829), Bertolacini et al. (2012) identified a heterozygous 2-bp deletion (864delCC) in the GLI2 gene, resulting in a frameshift and premature terminatin (Pro288fsTer301). The mutation, which was not found in 96 Brazilian controls, was inherited from the mother, who had postaxial polydactyly. The child had microcephaly, a large cleft lip/palate involving partially the premaxilla, and bilateral postaxial polydactyly. Evaluation at age 8 years showed severe neurodevelopmental delay, and brain MRI showed semilobar holoprosencephaly.</Attribute>
        <Citation Type="general">
          <ID Source="PubMed">21204792</ID>
        </Citation>
      </ObservedData>
      <ObservedData ID="2788085">
        <Attribute Type="Description">In a Brazilian girl with HPE9 (610829), Bertolacini et al. (2012) identified a heterozygous 2-bp deletion (864delCC) in the GLI2 gene, resulting in a frameshift and premature termination (Pro288fsTer301). The mutation, which was not found in 96 Brazilian controls, was inherited from the mother, who had postaxial polydactyly. The child had microcephaly, a large cleft lip/palate involving partially the premaxilla, and bilateral postaxial polydactyly. Evaluation at age 8 years showed severe neurodevelopmental delay, and brain MRI showed semilobar holoprosencephaly.</Attribute>
        <Citation Type="general">
          <ID Source="PubMed">21204792</ID>
        </Citation>
      </ObservedData>
      <ObservedData ID="2788085">
        <Attribute Type="Description">In a Brazilian girl with HPE9 (610829), Bertolacini et al. (2012) identified a heterozygous 2-bp deletion (864delCC) in the GLI2 gene, resulting in a frameshift and premature truncation (P288fsX301). The mutation, which was not found in 96 Brazilian controls, was inherited from the mother, who had postaxial polydactyly. The child had microcephaly, a large cleft lip/palate involving partially the premaxilla, and bilateral postaxial polydactyly. Evaluation at age 8 years showed severe neurodevelopmental delay, and brain MRI showed semilobar holoprosencephaly.</Attribute>
        <Citation Type="general">
          <ID Source="PubMed">21204792</ID>
        </Citation>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant" ID="37082">
      <Measure Type="Deletion" ID="45757">
        <Name>
          <ElementValue Type="Preferred">NM_005270.4(GLI2):c.864_865delCC (p.His289Profs)</ElementValue>
        </Name>
        <AttributeSet>
          <Attribute Type="HGVS, coding, RefSeq" Change="c.864_865delCC">NM_005270.4:c.864_865delCC</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, RefSeqGene" Change="g.178121_178122delCC">NG_009030.1:g.178121_178122delCC</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, top level" Change="g.120970411_120970412delCC">NC_000002.12:g.120970411_120970412delCC</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, top level, previous" Change="g.121727987_121727988delCC">NC_000002.11:g.121727987_121727988delCC</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, protein, RefSeq" Change="p.His289Profs">NP_005261.2:p.His289Profs</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="MolecularConsequence">frameshift variant</Attribute>
          <XRef ID="SO:0001589" DB="Sequence Ontology"/>
          <XRef ID="NM_005270.4:c.864_865delCC" DB="RefSeq"/>
        </AttributeSet>
        <CytogeneticLocation>2q14.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" Chr="2" Accession="NC_000002.11" start="121727987" stop="121727988"/>
        <SequenceLocation Assembly="GRCh38" Chr="2" Accession="NC_000002.12" start="120970411" stop="120970412"/>
        <MeasureRelationship Type="variant in gene">
          <Name>
            <ElementValue Type="Preferred">GLI family zinc finger 2</ElementValue>
          </Name>
          <Symbol>
            <ElementValue Type="Preferred">GLI2</ElementValue>
          </Symbol>
          <AttributeSet>
            <Attribute dateValue="2011-12-01" Type="Haploinsufficiency">Sufficient evidence for dosage pathogenicity</Attribute>
            <Citation>
              <URL>http://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLI2</URL>
            </Citation>
          </AttributeSet>
          <AttributeSet>
            <Attribute dateValue="2011-12-01" Type="Triplosensitivity">No evidence available</Attribute>
            <Citation>
              <URL>http://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLI2</URL>
            </Citation>
          </AttributeSet>
          <SequenceLocation Assembly="GRCh37" Chr="2" Accession="NC_000002.11" start="121554866" stop="121750228" Strand="+"/>
          <SequenceLocation Assembly="GRCh38" Chr="2" Accession="NC_000002.12" start="120797290" stop="120992652" Strand="+"/>
          <XRef ID="2736" DB="Gene"/>
          <XRef Type="MIM" ID="165230" DB="OMIM"/>
        </MeasureRelationship>
        <XRef Type="Allelic variant" ID="165230.0005" DB="OMIM"/>
        <XRef Type="rs" ID="398122882" DB="dbSNP"/>
      </Measure>
      <Name>
        <ElementValue Type="preferred name">NM_005270.4(GLI2):c.864_865delCC (p.His289Profs)</ElementValue>
      </Name>
    </MeasureSet>
    <TraitSet Type="Disease" ID="3820">
      <Trait ID="5262" Type="Disease">
        <Name>
          <ElementValue Type="Preferred">Holoprosencephaly 9</ElementValue>
          <XRef ID="Holoprosencephaly+9/8564" DB="Genetic Alliance"/>
        </Name>
        <Name>
          <ElementValue Type="Alternate">PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES</ElementValue>
          <XRef Type="MIM" ID="610829" DB="OMIM"/>
        </Name>
        <Name>
          <ElementValue Type="Alternate">HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES</ElementValue>
          <XRef Type="MIM" ID="610829" DB="OMIM"/>
        </Name>
        <Symbol>
          <ElementValue Type="Preferred">HPE9</ElementValue>
          <XRef Type="MIM" ID="610829" DB="OMIM"/>
        </Symbol>
        <AttributeSet>
          <Attribute Type="public definition">Holoprosencephaly (HPE) is a structural anomaly of the brain in which there is failed or incomplete separation of the forebrain early in gestation. Classic HPE encompasses a continuum of brain malformations including (in order of decreasing severity): alobar, semilobar, lobar, and middle interhemispheric variant (MIHV) type HPE; a septopreoptic type has also been described. Other CNS abnormalities not specific to HPE may also occur. HPE is accompanied by a spectrum of characteristic craniofacial anomalies in approximately 80% of individuals with HPE. Developmental delay is present in virtually all individuals with the HPE spectrum of CNS anomalies. Seizures and pituitary dysfunction are common. Most affected fetuses do not survive; severely affected children typically do not survive beyond early infancy, while a significant proportion of more mildly affected children survive past 12 months. Mildly manifesting individuals without appreciable brain anomalies on conventional neuroimaging may be described as having “microform” HPE.</Attribute>
          <XRef ID="NBK1530" DB="GeneReviews"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="age of onset">Neonatal/infancy</Attribute>
          <XRef ID="2162" DB="Orphanet"/>
        </AttributeSet>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301702</ID>
        </Citation>
        <XRef ID="C1835819" DB="MedGen"/>
        <XRef ID="2162" DB="Orphanet"/>
        <XRef Type="MIM" ID="610829" DB="OMIM"/>
      </Trait>
    </TraitSet>
  </ReferenceClinVarAssertion>
  <ClinVarAssertion ID="88492">
    <ClinVarSubmissionID localKey="165230.0005_HOLOPROSENCEPHALY 9" title="GLI2, 2-BP DEL, 864CC_HOLOPROSENCEPHALY 9" submitterDate="2014-01-24" submitter="OMIM"/>
    <ClinVarAccession Acc="SCV000053390" Version="3" Type="SCV" OrgID="3" DateUpdated="2014-06-28"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2014-01-24">
      <Description>Pathogenic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ExternalID DB="OMIM" Type="Allelic variant" ID="165230.0005"/>
    <ObservedIn>
      <Sample>
        <Origin>germline</Origin>
        <Species>human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData>
        <Attribute Type="Description">In a Brazilian girl with HPE9 (610829), Bertolacini et al. (2012) identified a heterozygous 2-bp deletion (864delCC) in the GLI2 gene, resulting in a frameshift and premature termination (Pro288fsTer301). The mutation, which was not found in 96 Brazilian controls, was inherited from the mother, who had postaxial polydactyly. The child had microcephaly, a large cleft lip/palate involving partially the premaxilla, and bilateral postaxial polydactyly. Evaluation at age 8 years showed severe neurodevelopmental delay, and brain MRI showed semilobar holoprosencephaly.</Attribute>
        <Citation>
          <ID Source="PubMed">21204792</ID>
        </Citation>
        <XRef DB="OMIM" Type="MIM" ID="610829"/>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant">
      <Measure Type="Variation">
        <Name>
          <ElementValue Type="Preferred">GLI2, 2-BP DEL, 864CC</ElementValue>
        </Name>
        <AttributeSet>
          <Attribute Type="NonHGVS">2-BP DEL, 864CC</Attribute>
        </AttributeSet>
        <MeasureRelationship Type="variant in gene">
          <Symbol>
            <ElementValue Type="Preferred">GLI2</ElementValue>
          </Symbol>
        </MeasureRelationship>
        <XRef DB="OMIM" Type="Allelic variant" ID="165230.0005"/>
      </Measure>
    </MeasureSet>
    <TraitSet Type="Disease">
      <Trait Type="Disease">
        <Name>
          <ElementValue Type="Preferred">HOLOPROSENCEPHALY 9</ElementValue>
        </Name>
      </Trait>
    </TraitSet>
  </ClinVarAssertion>
</ClinVarSet>
<ClinVarSet ID="3193940">
  <RecordStatus>current</RecordStatus>
  <Title>NM_001099274.1(TINF2):c.892delC (p.Gln298Argfs) AND Dyskeratosis congenita autosomal dominant</Title>
  <ReferenceClinVarAssertion DateCreated="2013-01-08" DateLastUpdated="2014-08-05" ID="92830">
    <ClinVarAccession Acc="RCV000032179" Version="1" Type="RCV" DateUpdated="2014-08-05"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2012-05-10">
      <ReviewStatus>classified by single submitter</ReviewStatus>
      <Description>Pathogenic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ObservedIn>
      <Sample>
        <Origin>not provided</Origin>
        <Species TaxonomyId="9606">human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <Purpose>assert pathogenicity</Purpose>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData ID="2785223">
        <Attribute Type="Description">not provided</Attribute>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant" ID="38928">
      <Measure Type="Deletion" ID="47531">
        <Name>
          <ElementValue Type="Preferred">NM_001099274.1(TINF2):c.892delC (p.Gln298Argfs)</ElementValue>
        </Name>
        <AttributeSet>
          <Attribute Type="HGVS, coding, RefSeq" Change="c.892delC">NM_001099274.1:c.892delC</Attribute>
          <XRef ID="NBK22301" DB="GeneReviews"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, RefSeqGene" Change="g.7087delC">NG_016650.1:g.7087delC</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, top level" Change="g.24240588delG">NC_000014.9:g.24240588delG</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, top level, previous" Change="g.24709794delG">NC_000014.8:g.24709794delG</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, protein, RefSeq" Change="p.Gln298Argfs">NP_001092744.1:p.Gln298Argfs</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="MolecularConsequence">frameshift variant</Attribute>
          <XRef ID="SO:0001589" DB="Sequence Ontology"/>
          <XRef ID="NM_001099274.1:c.892delC" DB="RefSeq"/>
        </AttributeSet>
        <CytogeneticLocation>14q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" Chr="14" Accession="NC_000014.8" start="24709794" stop="24709794" variantLength="1" referenceAllele="G" alternateAllele="-"/>
        <SequenceLocation Assembly="GRCh38" Chr="14" Accession="NC_000014.9" start="24240588" stop="24240588" variantLength="1" referenceAllele="G" alternateAllele="-"/>
        <MeasureRelationship Type="variant in gene">
          <Name>
            <ElementValue Type="Preferred">TERF1 (TRF1)-interacting nuclear factor 2</ElementValue>
          </Name>
          <Symbol>
            <ElementValue Type="Preferred">TINF2</ElementValue>
          </Symbol>
          <SequenceLocation Assembly="GRCh37" Chr="14" Accession="NC_000014.8" start="24708848" stop="24711879" Strand="-"/>
          <SequenceLocation Assembly="GRCh38" Chr="14" Accession="NC_000014.9" start="24234247" stop="24243026" Strand="-"/>
          <XRef ID="26277" DB="Gene"/>
          <XRef Type="MIM" ID="604319" DB="OMIM"/>
        </MeasureRelationship>
        <XRef ID="NBK22301" DB="GeneReviews"/>
        <XRef Type="rs" ID="199422320" DB="dbSNP"/>
      </Measure>
      <Name>
        <ElementValue Type="preferred name">NM_001099274.1(TINF2):c.892delC (p.Gln298Argfs)</ElementValue>
      </Name>
    </MeasureSet>
    <TraitSet Type="Disease" ID="1583">
      <Trait ID="4974" Type="Disease">
        <Name>
          <ElementValue Type="Preferred">Dyskeratosis congenita autosomal dominant</ElementValue>
          <XRef ID="Dyskeratosis+Congenita+Autosomal+Dominant/2383" DB="Genetic Alliance"/>
          <XRef ID="6299" DB="Office of Rare Diseases"/>
        </Name>
        <Name>
          <ElementValue Type="Alternate">DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1</ElementValue>
          <XRef Type="MIM" ID="127550" DB="OMIM"/>
          <XRef Type="Allelic variant" ID="602322.0003" DB="OMIM"/>
          <XRef Type="Allelic variant" ID="602322.0001" DB="OMIM"/>
          <XRef Type="Allelic variant" ID="602322.0002" DB="OMIM"/>
          <XRef Type="Allelic variant" ID="602322.0011" DB="OMIM"/>
        </Name>
        <Name>
          <ElementValue Type="Alternate">Dyskeratosis Congenita</ElementValue>
          <XRef ID="NBK22301" DB="GeneReviews"/>
        </Name>
        <Symbol>
          <ElementValue Type="Preferred">DKCA1</ElementValue>
          <XRef Type="MIM" ID="127550" DB="OMIM"/>
        </Symbol>
        <Symbol>
          <ElementValue Type="Alternate">DKCA</ElementValue>
          <XRef ID="6299" DB="Office of Rare Diseases"/>
        </Symbol>
        <AttributeSet>
          <Attribute Type="public definition">Dyskeratosis congenita (DC), a telomere biology disorder, is characterized by a classic triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia. However, the classic triad may not be present in all individuals. People with DC are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML), solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include: abnormal pigmentation changes not restricted to the upper chest and neck, eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), and dental abnormalities (caries, periodontal disease, taurodauntism). Although most persons with DC have normal psychomotor development and normal neurologic function, significant developmental delay is present in the two variants in which additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome). Onset and progression of manifestations of DC vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
          <XRef ID="NBK22301" DB="GeneReviews"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance" integerValue="263">Autosomal recessive inheritance</Attribute>
          <XRef ID="GTR000319388" DB="Ambry Genetics"/>
          <XRef ID="GTR000298122" DB="DNA Diagnostic Laboratory at Johns Hopkins,Johns Hopkins Hospital"/>
          <XRef ID="GTR000510772" DB="Centogene AG  - the Rare Disease Company,Centogene AG"/>
          <XRef ID="GTR000510773" DB="Centogene AG  - the Rare Disease Company,Centogene AG"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance" integerValue="262">Autosomal dominant inheritance</Attribute>
          <XRef ID="GTR000319384" DB="Ambry Genetics"/>
          <XRef ID="GTR000319388" DB="Ambry Genetics"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="age of onset">Childhood</Attribute>
          <XRef ID="1775" DB="Orphanet"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="prevalence">1-9 / 1 000 000</Attribute>
          <XRef ID="1775" DB="Orphanet"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="mode of inheritance">Variable</Attribute>
          <XRef ID="GTR000319389" DB="Ambry Genetics"/>
        </AttributeSet>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301779</ID>
        </Citation>
        <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
          <ID Source="PubMed">21610750</ID>
        </Citation>
        <XRef ID="NBK22301" DB="GeneReviews"/>
        <XRef ID="C1851970" DB="MedGen"/>
        <XRef ID="1775" DB="Orphanet"/>
        <XRef Type="MIM" ID="127550" DB="OMIM"/>
      </Trait>
    </TraitSet>
  </ReferenceClinVarAssertion>
  <ClinVarAssertion ID="92228">
    <ClinVarSubmissionID title="NM_001099274.1:c.892delC and Dyskeratosis Congenita" localKey="NM_001099274.1:c.892delC_NBK22301" submitterDate="2013-01-08" submitter="GeneReviews"/>
    <ClinVarAccession Acc="SCV000055758" Version="1" Type="SCV" OrgID="500062" DateUpdated="2014-06-28"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2012-05-10">
      <Description>pathologic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ExternalID DB="GeneReviews" ID="NBK22301"/>
    <ObservedIn>
      <Sample>
        <Origin>not provided</Origin>
        <Species>human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <Purpose>Assert pathogenicity</Purpose>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData>
        <Attribute Type="Description">not provided</Attribute>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant">
      <Measure Type="Variation">
        <AttributeSet>
          <Attribute Type="HGVS">NM_001099274.1:c.892delC</Attribute>
        </AttributeSet>
        <XRef DB="dbSNP" ID="199422320"/>
      </Measure>
    </MeasureSet>
    <TraitSet Type="Disease">
      <Trait Type="Disease">
        <Name>
          <ElementValue Type="Preferred">Dyskeratosis Congenita</ElementValue>
        </Name>
        <XRef DB="GeneReviews" ID="NBK22301"/>
        <XRef DB="OMIM" Type="MIM Number" ID="127550"/>
      </Trait>
    </TraitSet>
  </ClinVarAssertion>
</ClinVarSet>
<ClinVarSet ID="3104906">
  <RecordStatus>current</RecordStatus>
  <Title>NM_207352.3:c.1226-6_1235del16 AND Bietti crystalline corneoretinal dystrophy</Title>
  <ReferenceClinVarAssertion DateCreated="2013-01-08" DateLastUpdated="2014-07-22" ID="93183">
    <ClinVarAccession Acc="RCV000032532" Version="2" Type="RCV" DateUpdated="2014-07-23"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2012-04-12">
      <ReviewStatus>classified by single submitter</ReviewStatus>
      <Description>Pathogenic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ObservedIn>
      <Sample>
        <Origin>not provided</Origin>
        <Species TaxonomyId="9606">human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <Purpose>assert pathogenicity</Purpose>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData ID="2674569">
        <Attribute Type="Description">not provided</Attribute>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant" ID="39255">
      <Measure Type="Deletion" ID="47861">
        <Name>
          <ElementValue Type="preferred name">NM_207352.3:c.1226-6_1235del16</ElementValue>
        </Name>
        <AttributeSet>
          <Attribute Type="HGVS, coding" Change="c.1226-6_1235delTGACAGCAGGTTACAG">NM_207352.3:c.1226-6_1235delTGACAGCAGGTTACAG</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, coding, RefSeq" Change="c.1226-6_1235del16">NM_207352.3:c.1226-6_1235del16</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic" Change="g.22568_22583delTGACAGCAGGTTACAG">NG_007965.1:g.22568_22583delTGACAGCAGGTTACAG</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, RefSeqGene" Change="g.22568_22583del16">NG_007965.1:g.22568_22583del16</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, top level" Change="g.186209087_186209102del16">NC_000004.12:g.186209087_186209102del16</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, top level, previous" Change="g.187130241_187130256del16">NC_000004.11:g.187130241_187130256del16</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, non-validated">NM_207352.3:c.1226-6delTGACAG_1226_1235delCAGGTTACAG</Attribute>
          <XRef ID="NBK91457" DB="GeneReviews"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="nucleotide change">IVS9-6del</Attribute>
          <XRef ID="NBK91457" DB="GeneReviews"/>
        </AttributeSet>
        <CytogeneticLocation>4q35.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" Chr="4" Accession="NC_000004.11" start="187130241" stop="187130256"/>
        <SequenceLocation Assembly="GRCh38" Chr="4" Accession="NC_000004.12" start="186209087" stop="186209102"/>
        <MeasureRelationship Type="variant in gene">
          <Name>
            <ElementValue Type="Preferred">cytochrome P450, family 4, subfamily V, polypeptide 2</ElementValue>
          </Name>
          <Symbol>
            <ElementValue Type="Preferred">CYP4V2</ElementValue>
          </Symbol>
          <SequenceLocation Assembly="GRCh37" Chr="4" Accession="NC_000004.11" start="187112673" stop="187134616" Strand="+"/>
          <SequenceLocation Assembly="GRCh38" Chr="4" Accession="NC_000004.12" start="186191410" stop="186213462" Strand="+"/>
          <XRef ID="285440" DB="Gene"/>
          <XRef Type="MIM" ID="608614" DB="OMIM"/>
        </MeasureRelationship>
        <Citation Type="general">
          <ID Source="PubMed">16179904</ID>
        </Citation>
        <XRef Type="rs" ID="199476184" DB="dbSNP"/>
      </Measure>
      <Name>
        <ElementValue Type="preferred name">NM_207352.3:c.1226-6_1235del16</ElementValue>
      </Name>
    </MeasureSet>
    <TraitSet Type="Disease" ID="559">
      <Trait ID="4671" Type="Disease">
        <Name>
          <ElementValue Type="Preferred">Bietti crystalline corneoretinal dystrophy</ElementValue>
          <XRef ID="Bietti+Crystalline+Corneoretinal+Dystrophy/825" DB="Genetic Alliance"/>
          <XRef ID="10050" DB="Office of Rare Diseases"/>
        </Name>
        <Name>
          <ElementValue Type="Alternate">Bietti tapetoretinal degeneration with marginal corneal dystrophy</ElementValue>
        </Name>
        <Name>
          <ElementValue Type="Alternate">Bietti Crystalline Dystrophy</ElementValue>
          <XRef ID="NBK91457" DB="GeneReviews"/>
        </Name>
        <Symbol>
          <ElementValue Type="Preferred">BCD</ElementValue>
          <XRef Type="MIM" ID="210370" DB="OMIM"/>
          <XRef ID="10050" DB="Office of Rare Diseases"/>
        </Symbol>
        <AttributeSet>
          <Attribute Type="public definition">Bietti crystalline dystrophy (BCD) is a chorioretinal degeneration characterized by the presence of yellow-white crystals and/or complex lipid deposits in the retina. Progressive atrophy and degeneration of the retinal pigment epithelium (RPE)/choroid lead to symptoms similar to those of other forms of retinal degeneration that fall under the category of retinitis pigmentosa and allied disorders, namely: reduced visual acuity, poor night vision, abnormal retinal electrophysiology, visual field loss, and often impaired color vision. Marked asymmetry between eyes is common. Onset is typically during the second to third decade of life, but ranges from the early teenage years to beyond the third decade. With time, loss of peripheral visual field, central acuity, or both result in legal blindness in most, if not all, affected individuals.</Attribute>
          <XRef ID="NBK91457" DB="GeneReviews"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance" integerValue="263">Autosomal recessive inheritance</Attribute>
          <XRef Type="MIM" ID="210370" DB="OMIM"/>
          <XRef ID="GTR000512554" DB="Asper Biotech ,Asper Biotech Ltd."/>
          <XRef ID="GTR000506412" DB="Fulgent Clinical Diagnostics Lab,Fulgent Diagnostics "/>
        </AttributeSet>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">22497028</ID>
        </Citation>
        <XRef ID="NBK91457" DB="GeneReviews"/>
        <XRef ID="C1859486" DB="MedGen"/>
        <XRef Type="MIM" ID="210370" DB="OMIM"/>
      </Trait>
    </TraitSet>
  </ReferenceClinVarAssertion>
  <ClinVarAssertion ID="92670">
    <ClinVarSubmissionID title="IVS9-6del and Bietti Crystalline Dystrophy" localKey="IVS9-6del_NBK91457" submitterDate="2013-03-26" submitter="GeneReviews"/>
    <ClinVarAccession Acc="SCV000056195" Version="2" Type="SCV" OrgID="500062" DateUpdated="2014-06-28"/>
    <RecordStatus>replaced</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2012-04-12">
      <Description>pathologic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ExternalID DB="GeneReviews" ID="NBK91457"/>
    <ObservedIn>
      <Sample>
        <Origin>not provided</Origin>
        <Species>human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <Purpose>Assert pathogenicity</Purpose>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData>
        <Attribute Type="Description">not provided</Attribute>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant">
      <Measure Type="Variation">
        <AttributeSet>
          <Attribute Type="nucleotide change">IVS9-6del</Attribute>
        </AttributeSet>
      </Measure>
    </MeasureSet>
    <TraitSet Type="Disease">
      <Trait Type="Disease">
        <Name>
          <ElementValue Type="Preferred">Bietti Crystalline Dystrophy</ElementValue>
        </Name>
        <XRef DB="GeneReviews" ID="NBK91457"/>
        <XRef DB="OMIM" Type="MIM" ID="210370"/>
      </Trait>
    </TraitSet>
  </ClinVarAssertion>
</ClinVarSet>
<ClinVarSet ID="3194294">
  <RecordStatus>current</RecordStatus>
  <Title>NM_207352.3(CYP4V2):c.759dupA (p.His254Thrfs) AND Bietti crystalline corneoretinal dystrophy</Title>
  <ReferenceClinVarAssertion DateCreated="2013-01-08" DateLastUpdated="2014-08-05" ID="93197">
    <ClinVarAccession Acc="RCV000032546" Version="2" Type="RCV" DateUpdated="2014-08-05"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2012-04-12">
      <ReviewStatus>classified by single submitter</ReviewStatus>
      <Description>Pathogenic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ObservedIn>
      <Sample>
        <Origin>not provided</Origin>
        <Species TaxonomyId="9606">human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <Purpose>assert pathogenicity</Purpose>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData ID="2780007">
        <Attribute Type="Description">not provided</Attribute>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant" ID="39269">
      <Measure Type="Duplication" ID="47875">
        <Name>
          <ElementValue Type="Preferred">NM_207352.3(CYP4V2):c.759dupA (p.His254Thrfs)</ElementValue>
        </Name>
        <AttributeSet>
          <Attribute Type="HGVS, coding, RefSeq" Change="c.759dupA">NM_207352.3:c.759dupA</Attribute>
          <XRef ID="NBK91457" DB="GeneReviews"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, RefSeqGene" Change="g.12522dupA">NG_007965.1:g.12522dupA</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, top level" Change="g.186199041dupA">NC_000004.12:g.186199041dupA</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, top level, previous" Change="g.187120195dupA">NC_000004.11:g.187120195dupA</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="HGVS, protein, RefSeq" Change="p.His254Thrfs">NP_997235.3:p.His254Thrfs</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="MolecularConsequence">frameshift variant</Attribute>
          <XRef ID="SO:0001589" DB="Sequence Ontology"/>
          <XRef ID="NM_207352.3:c.759_760insA" DB="RefSeq"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="nucleotide change">c.1062_1063dupA</Attribute>
          <XRef ID="NBK91457" DB="GeneReviews"/>
        </AttributeSet>
        <CytogeneticLocation>4q35.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" Chr="4" Accession="NC_000004.12" start="186199041" stop="186199042" variantLength="2" referenceAllele="A" alternateAllele="AA"/>
        <SequenceLocation Assembly="GRCh37" Chr="4" Accession="NC_000004.11" start="187120195" stop="187120196" variantLength="2" referenceAllele="A" alternateAllele="AA"/>
        <MeasureRelationship Type="variant in gene">
          <Name>
            <ElementValue Type="Preferred">cytochrome P450, family 4, subfamily V, polypeptide 2</ElementValue>
          </Name>
          <Symbol>
            <ElementValue Type="Preferred">CYP4V2</ElementValue>
          </Symbol>
          <SequenceLocation Assembly="GRCh37" Chr="4" Accession="NC_000004.11" start="187112673" stop="187134616" Strand="+"/>
          <SequenceLocation Assembly="GRCh38" Chr="4" Accession="NC_000004.12" start="186191410" stop="186213462" Strand="+"/>
          <XRef ID="285440" DB="Gene"/>
          <XRef Type="MIM" ID="608614" DB="OMIM"/>
        </MeasureRelationship>
        <XRef ID="NBK91457" DB="GeneReviews"/>
        <XRef Type="rs" ID="199476192" DB="dbSNP"/>
      </Measure>
      <Name>
        <ElementValue Type="preferred name">NM_207352.3(CYP4V2):c.759dupA (p.His254Thrfs)</ElementValue>
      </Name>
    </MeasureSet>
    <TraitSet Type="Disease" ID="559">
      <Trait ID="4671" Type="Disease">
        <Name>
          <ElementValue Type="Preferred">Bietti crystalline corneoretinal dystrophy</ElementValue>
          <XRef ID="Bietti+Crystalline+Corneoretinal+Dystrophy/825" DB="Genetic Alliance"/>
          <XRef ID="10050" DB="Office of Rare Diseases"/>
        </Name>
        <Name>
          <ElementValue Type="Alternate">Bietti tapetoretinal degeneration with marginal corneal dystrophy</ElementValue>
        </Name>
        <Name>
          <ElementValue Type="Alternate">Bietti Crystalline Dystrophy</ElementValue>
          <XRef ID="NBK91457" DB="GeneReviews"/>
        </Name>
        <Symbol>
          <ElementValue Type="Preferred">BCD</ElementValue>
          <XRef Type="MIM" ID="210370" DB="OMIM"/>
          <XRef ID="10050" DB="Office of Rare Diseases"/>
        </Symbol>
        <AttributeSet>
          <Attribute Type="public definition">Bietti crystalline dystrophy (BCD) is a chorioretinal degeneration characterized by the presence of yellow-white crystals and/or complex lipid deposits in the retina. Progressive atrophy and degeneration of the retinal pigment epithelium (RPE)/choroid lead to symptoms similar to those of other forms of retinal degeneration that fall under the category of retinitis pigmentosa and allied disorders, namely: reduced visual acuity, poor night vision, abnormal retinal electrophysiology, visual field loss, and often impaired color vision. Marked asymmetry between eyes is common. Onset is typically during the second to third decade of life, but ranges from the early teenage years to beyond the third decade. With time, loss of peripheral visual field, central acuity, or both result in legal blindness in most, if not all, affected individuals.</Attribute>
          <XRef ID="NBK91457" DB="GeneReviews"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance" integerValue="263">Autosomal recessive inheritance</Attribute>
          <XRef Type="MIM" ID="210370" DB="OMIM"/>
          <XRef ID="GTR000512554" DB="Asper Biotech ,Asper Biotech Ltd."/>
          <XRef ID="GTR000506412" DB="Fulgent Clinical Diagnostics Lab,Fulgent Diagnostics "/>
        </AttributeSet>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">22497028</ID>
        </Citation>
        <XRef ID="NBK91457" DB="GeneReviews"/>
        <XRef ID="C1859486" DB="MedGen"/>
        <XRef Type="MIM" ID="210370" DB="OMIM"/>
      </Trait>
    </TraitSet>
  </ReferenceClinVarAssertion>
  <ClinVarAssertion ID="92688">
    <ClinVarSubmissionID title="c.1062_1063dupA and Bietti Crystalline Dystrophy" localKey="c.1062_1063dupA_NBK91457" submitterDate="2013-03-26" submitter="GeneReviews"/>
    <ClinVarAccession Acc="SCV000056213" Version="2" Type="SCV" OrgID="500062" DateUpdated="2014-06-28"/>
    <RecordStatus>replaced</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2012-04-12">
      <Description>pathologic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ExternalID DB="GeneReviews" ID="NBK91457"/>
    <ObservedIn>
      <Sample>
        <Origin>not provided</Origin>
        <Species>human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <Purpose>Assert pathogenicity</Purpose>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData>
        <Attribute Type="Description">not provided</Attribute>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant">
      <Measure Type="Variation">
        <AttributeSet>
          <Attribute Type="nucleotide change">c.1062_1063dupA</Attribute>
        </AttributeSet>
      </Measure>
    </MeasureSet>
    <TraitSet Type="Disease">
      <Trait Type="Disease">
        <Name>
          <ElementValue Type="Preferred">Bietti Crystalline Dystrophy</ElementValue>
        </Name>
        <XRef DB="GeneReviews" ID="NBK91457"/>
        <XRef DB="OMIM" Type="MIM" ID="210370"/>
      </Trait>
    </TraitSet>
  </ClinVarAssertion>
</ClinVarSet>
<ClinVarSet ID="2881615">
  <RecordStatus>current</RecordStatus>
  <Title>m.7472_7473insC AND Mitochondrial cytochrome c oxidase deficiency</Title>
  <ReferenceClinVarAssertion DateCreated="2012-08-13" DateLastUpdated="2014-06-27" ID="67681">
    <ClinVarAccession Acc="RCV000010178" Version="1" Type="RCV" DateUpdated="2014-06-28"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2013-03-19">
      <ReviewStatus>classified by single submitter</ReviewStatus>
      <Description>Pathogenic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ObservedIn>
      <Sample>
        <Origin>germline</Origin>
        <Species TaxonomyId="9606">human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData ID="2536011">
        <Attribute Type="Description">Jaksch et al. (1998) identified a 1-bp insertion at nucleotide 7472 of the MTTS1 gene in 2 patients with mitochondrial encephalopathy with cytochrome c oxidase deficiency associated with sensorineural hearing loss, ataxia, myoclonic epilepsy, and mental retardation.</Attribute>
        <Citation Type="general">
          <ID Source="PubMed">9832034</ID>
        </Citation>
      </ObservedData>
      <ObservedData ID="2536011">
        <Attribute Type="Description">Toompuu et al. (1999) performed studies of the 7472insC mutation in osteosarcoma cell cybrids. They found no evidence for a specific defect in aminoacylation, and unlike the case with the np 7445 mutation, which is also associated with deafness, the pattern of RNA processing of light strand transcripts of the ND6 region was not systematically altered. Comparison of the np 7472 and np 7445 mutant phenotypes in cultured cells suggested that sensorineural deafness can result from a functional insufficiency of mitochondrial tRNA-ser, to which some cells of the auditory system are especially vulnerable.</Attribute>
        <Citation Type="general">
          <ID Source="PubMed">10545608</ID>
        </Citation>
      </ObservedData>
      <ObservedData ID="2536011">
        <Attribute Type="Description">In 6 Western European families with the heteroplasmic 7472insC mutation in the MTTS1 gene, Hutchin et al. (2001) performed mtDNA haplotype analysis on the basis of 10 polymorphic restriction enzyme sites. The families were assigned to haplogroups K, V, and H. There were 4 families in haplogroup H, which is the most common European haplogroup (approximately 40%). Sequence analysis of the D-loop region showed that the 4 haplogroup H families were not closely related, supporting that the 7472insC mutation had occurred multiple times in the European population. The presence of the same mutation on separate mtDNA backgrounds confirmed the notion that the 7472insC mutation alone is sufficient to cause hearing loss and that when present at very high levels can also lead to neurologic dysfunction.</Attribute>
        <Citation Type="general">
          <ID Source="PubMed">11378827</ID>
        </Citation>
      </ObservedData>
      <ObservedData ID="2536011">
        <Attribute Type="Description">In a Sicilian family with maternally inherited hearing loss as a predominant feature, Tiranti et al. (1995) found the insertion of a C at nucleotide position 7472 of the MTTS1 gene. In 6 of 9 patients, the hearing loss was accompanied by ataxia, dysarthria, and focal myoclonus. Verhoeven et al. (1999) reported a Dutch family with maternally inherited, progressive, sensorineural hearing loss (500008) in 27 patients with the same mutation. They determined the percentage of mutant DNA (heteroplasmy) in blood from all family members, and found no correlation between hearing loss and leukocyte heteroplasmy. However, in the Dutch family, only a single family member with hearing loss showed accompanying neurologic symptoms including ataxia and dysarthria. Verhoeven et al. (1999) suggested that modifying secondary factors must account for the interfamilial differences in penetrance of the neurologic abnormalities. They concluded, furthermore, that this mutation should be analyzed in patients with maternally inherited hearing loss, irrespective of whether the hearing loss is nonsyndromic or accompanied by neurologic abnormalities. Three members with the 7472insC mutation developed hearing loss after the use of aminoglycosides. For this reason, Verhoeven et al. (1999) analyzed for this mutation in 52 patients who suffered from acute hearing loss after the use of aminoglycosides; 43 of these patients were unrelated. In 7 of the 43, the 1555A-G mutation (561000.0001) in the MTRNR1 gene was found, but the 7472insC mutation was not detected in any of them. This was the third mitochondrial mutation identified as the cause of hearing loss, the others being 1555A-G and 7445A-G (590080.0002), which is also in the MTTS1 gene.</Attribute>
        <Citation Type="general">
          <ID Source="PubMed">10094190</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7581383</ID>
        </Citation>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant" ID="9564">
      <Measure Type="Insertion" ID="24603">
        <Name>
          <ElementValue Type="Preferred">m.7472_7473insC</ElementValue>
        </Name>
        <AttributeSet>
          <Attribute Type="HGVS, genomic, top level" Change="m.7472_7473insC">NC_012920.1:m.7472_7473insC</Attribute>
        </AttributeSet>
        <SequenceLocation Assembly="GRCh37" Chr="MT" Accession="NC_012920.1" start="7472" stop="7473"/>
        <SequenceLocation Assembly="GRCh38" Chr="MT" Accession="NC_012920.1" start="7472" stop="7473"/>
        <MeasureRelationship Type="variant in gene">
          <Name>
            <ElementValue Type="Preferred">mitochondrially encoded tRNA serine 1 (UCN)</ElementValue>
          </Name>
          <Symbol>
            <ElementValue Type="Preferred">MT-TS1</ElementValue>
          </Symbol>
          <SequenceLocation Assembly="GRCh38" Chr="MT" Accession="NC_012920.1" start="7446" stop="7514" Strand="-"/>
          <XRef ID="4574" DB="Gene"/>
          <XRef Type="MIM" ID="590080" DB="OMIM"/>
        </MeasureRelationship>
        <XRef Type="Allelic variant" ID="590080.0003" DB="OMIM"/>
        <XRef Type="rs" ID="199474819" DB="dbSNP"/>
      </Measure>
      <Name>
        <ElementValue Type="preferred name">m.7472_7473insC</ElementValue>
      </Name>
    </MeasureSet>
    <TraitSet Type="Disease" ID="2634">
      <Trait ID="10565" Type="Disease">
        <Name>
          <ElementValue Type="Preferred">Mitochondrial cytochrome c oxidase deficiency</ElementValue>
        </Name>
      </Trait>
    </TraitSet>
  </ReferenceClinVarAssertion>
  <ClinVarAssertion ID="30399">
    <ClinVarSubmissionID localKey="590080.0003_MITOCHONDRIAL CYTOCHROME c OXIDASE DEFICIENCY" title="MTTS1, 1-BP INS, 7472C_MITOCHONDRIAL CYTOCHROME c OXIDASE DEFICIENCY" submitterDate="2013-03-19" submitter="OMIM"/>
    <ClinVarAccession Acc="SCV000030399" Version="1" Type="SCV" OrgID="3" DateUpdated="2014-06-28"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2013-03-19">
      <Description>Pathogenic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ExternalID DB="OMIM" Type="Allelic variant" ID="590080.0003"/>
    <ObservedIn>
      <Sample>
        <Origin>germline</Origin>
        <Species>human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData>
        <Attribute Type="Description">Jaksch et al. (1998) identified a 1-bp insertion at nucleotide 7472 of the MTTS1 gene in 2 patients with mitochondrial encephalopathy with cytochrome c oxidase deficiency associated with sensorineural hearing loss, ataxia, myoclonic epilepsy, and mental retardation.</Attribute>
        <Citation>
          <ID Source="PubMed">9832034</ID>
        </Citation>
      </ObservedData>
      <ObservedData>
        <Attribute Type="Description">In a Sicilian family with maternally inherited hearing loss as a predominant feature, Tiranti et al. (1995) found the insertion of a C at nucleotide position 7472 of the MTTS1 gene. In 6 of 9 patients, the hearing loss was accompanied by ataxia, dysarthria, and focal myoclonus. Verhoeven et al. (1999) reported a Dutch family with maternally inherited, progressive, sensorineural hearing loss (500008) in 27 patients with the same mutation. They determined the percentage of mutant DNA (heteroplasmy) in blood from all family members, and found no correlation between hearing loss and leukocyte heteroplasmy. However, in the Dutch family, only a single family member with hearing loss showed accompanying neurologic symptoms including ataxia and dysarthria. Verhoeven et al. (1999) suggested that modifying secondary factors must account for the interfamilial differences in penetrance of the neurologic abnormalities. They concluded, furthermore, that this mutation should be analyzed in patients with maternally inherited hearing loss, irrespective of whether the hearing loss is nonsyndromic or accompanied by neurologic abnormalities. Three members with the 7472insC mutation developed hearing loss after the use of aminoglycosides. For this reason, Verhoeven et al. (1999) analyzed for this mutation in 52 patients who suffered from acute hearing loss after the use of aminoglycosides; 43 of these patients were unrelated. In 7 of the 43, the 1555A-G mutation (561000.0001) in the MTRNR1 gene was found, but the 7472insC mutation was not detected in any of them. This was the third mitochondrial mutation identified as the cause of hearing loss, the others being 1555A-G and 7445A-G (590080.0002), which is also in the MTTS1 gene.</Attribute>
        <Citation>
          <ID Source="PubMed">7581383</ID>
        </Citation>
        <Citation>
          <ID Source="PubMed">10094190</ID>
        </Citation>
        <XRef DB="OMIM" Type="MIM" ID="500008"/>
      </ObservedData>
      <ObservedData>
        <Attribute Type="Description">Toompuu et al. (1999) performed studies of the 7472insC mutation in osteosarcoma cell cybrids. They found no evidence for a specific defect in aminoacylation, and unlike the case with the np 7445 mutation, which is also associated with deafness, the pattern of RNA processing of light strand transcripts of the ND6 region was not systematically altered. Comparison of the np 7472 and np 7445 mutant phenotypes in cultured cells suggested that sensorineural deafness can result from a functional insufficiency of mitochondrial tRNA-ser, to which some cells of the auditory system are especially vulnerable.</Attribute>
        <Citation>
          <ID Source="PubMed">10545608</ID>
        </Citation>
      </ObservedData>
      <ObservedData>
        <Attribute Type="Description">In 6 Western European families with the heteroplasmic 7472insC mutation in the MTTS1 gene, Hutchin et al. (2001) performed mtDNA haplotype analysis on the basis of 10 polymorphic restriction enzyme sites. The families were assigned to haplogroups K, V, and H. There were 4 families in haplogroup H, which is the most common European haplogroup (approximately 40%). Sequence analysis of the D-loop region showed that the 4 haplogroup H families were not closely related, supporting that the 7472insC mutation had occurred multiple times in the European population. The presence of the same mutation on separate mtDNA backgrounds confirmed the notion that the 7472insC mutation alone is sufficient to cause hearing loss and that when present at very high levels can also lead to neurologic dysfunction.</Attribute>
        <Citation>
          <ID Source="PubMed">11378827</ID>
        </Citation>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant">
      <Measure Type="Variation">
        <Name>
          <ElementValue Type="Preferred">MTTS1, 1-BP INS, 7472C</ElementValue>
        </Name>
        <AttributeSet>
          <Attribute Type="NonHGVS">1-BP INS, 7472C</Attribute>
        </AttributeSet>
        <MeasureRelationship Type="variant in gene">
          <Symbol>
            <ElementValue Type="Preferred">MTTS1</ElementValue>
          </Symbol>
        </MeasureRelationship>
        <XRef DB="OMIM" Type="Allelic variant" ID="590080.0003"/>
      </Measure>
    </MeasureSet>
    <TraitSet Type="Disease">
      <Trait Type="Disease">
        <Name>
          <ElementValue Type="Preferred">MITOCHONDRIAL CYTOCHROME c OXIDASE DEFICIENCY</ElementValue>
        </Name>
      </Trait>
    </TraitSet>
  </ClinVarAssertion>
</ClinVarSet>

</ReleaseSet>

